Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sodium-Glucose Cotransporter-2 Inhibitors Stabilize Coronary Plaques in Acute Coronary Syndrome With Diabetes Mellitus.
Kurozumi A, Shishido K, Yamashita T, Sato D, Uchida S, Koyama E, Tamaki Y, Hayashi T, Miyashita H, Yokoyama H, Ochiai T, Yamaguchi M, Moriyama N, Tobita K, Matsumoto T, Mizuno S, Yamanaka F, Tanaka Y, Murakami M, Takahashi S, Saito S. Kurozumi A, et al. Am J Cardiol. 2024 Mar 1;214:47-54. doi: 10.1016/j.amjcard.2023.12.056. Epub 2024 Jan 10. Am J Cardiol. 2024. PMID: 38215815
Blood pressure reduction with empagliflozin in Japanese patients with type 2 diabetes and cardiovascular diseases: a post-hoc sub-analysis of the placebo-controlled randomized EMBLEM trial.
Tanaka A, Shimabukuro M, Teragawa H, Yoshida H, Okada Y, Takamura T, Taguchi I, Toyoda S, Tomiyama H, Ueda S, Higashi Y, Node K; EMBLEM Investigators. Tanaka A, et al. Hypertens Res. 2024 Sep;47(9):2295-2302. doi: 10.1038/s41440-024-01725-4. Epub 2024 May 24. Hypertens Res. 2024. PMID: 38789538 Clinical Trial.
Comparative effects of fixed-dose mitiglinide/voglibose combination and glimepiride on vascular endothelial function and glycemic variability in patients with type 2 diabetes: A randomized controlled trial.
Tanaka K, Okada Y, Umezu S, Hashimoto R, Tomoyose Y, Tateyama R, Hori Y, Saito M, Tokutsu A, Sonoda S, Uemura F, Kurozumi A, Tanaka Y. Tanaka K, et al. Among authors: kurozumi a. J Diabetes Investig. 2024 Apr;15(4):449-458. doi: 10.1111/jdi.14138. Epub 2023 Dec 27. J Diabetes Investig. 2024. PMID: 38149694 Free PMC article. Clinical Trial.
Automated Feeder-Detection Software for Renal Cell Carcinoma Embolization: A Retrospective Evaluation of Detection Rate Using Transarterial Time-Resolved Computed Tomography Angiography.
Matsui Y, Tomita K, Uka M, Umakoshi N, Kawabata T, Munetomo K, Nagata S, Kurozumi A, Ujifuku A, Iguchi T, Hiraki T. Matsui Y, et al. Among authors: kurozumi a. Cardiovasc Intervent Radiol. 2024 Jan;47(1):132-138. doi: 10.1007/s00270-023-03611-x. Epub 2023 Nov 27. Cardiovasc Intervent Radiol. 2024. PMID: 38010507
Continuous glucose monitoring-derived time in range and CV are associated with altered tissue characteristics of the carotid artery wall in people with type 2 diabetes.
Mita T, Katakami N, Okada Y, Yoshii H, Osonoi T, Nishida K, Shiraiwa T, Kurozumi A, Taya N, Wakasugi S, Sato F, Ishii R, Gosho M, Shimomura I, Watada H. Mita T, et al. Among authors: kurozumi a. Diabetologia. 2023 Dec;66(12):2356-2367. doi: 10.1007/s00125-023-06013-3. Epub 2023 Sep 26. Diabetologia. 2023. PMID: 37750893 Free PMC article.
108 results